GSK Investigational Site

Rheinstetten, Baden-Wurttemberg 76287

0 studies enrolling now · 2 studies all time

What they study most

Infections, Papillomavirus

Studies at this site

• Gynaecological Follow-up of a Subset of 580299/008 (NCT00122681) Study Subjects — Completed
• Human Papilloma Virus (HPV) Vaccine Efficacy Trial Against Cervical Pre-cancer in Young Adults With GlaxoSmithKline (GSK) Biologicals HPV-16/18 — Completed